Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of YIC therapeutic vaccine plus tenofovir in chronic hepatitis B
ChiCTR2000040274Phase 2Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Nov 2020
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of YIC and tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by Union Hospital. Primary endpoint: HBsAg negative conversion rate. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
YICtenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2000040274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040274.